Genetic and teratogenic effects of cancer treatments on gametes and embryos
- PMID: 11476352
- DOI: 10.1093/humupd/7.4.394
Genetic and teratogenic effects of cancer treatments on gametes and embryos
Abstract
Male and female germ cells vary in their sensitivity to the mutagenic effects of chemotherapy and radiotherapy, depending on their stage of maturation and the agent used. Although sperm DNA damage exists following treatment, no increase in genetic defects or congenital malformations was detected among children conceived to parents who have previously undergone chemotherapy or radiotherapy. The use of assisted reproductive technologies and micromanipulation techniques might increase this risk; hence caution should be exercised. In female cancer patients, miscarriage and congenital malformations are not increased following chemotherapy. However, when IVF and embryo cryopreservation is practised between or shortly after treatment, possible genetic risks to the growing oocytes exist, and hence the babies should be screened. During pregnancy, the potential teratogenic effects of chemotherapy influence the choice and timing of therapy. Termination is usually recommended in the first trimester. Second- and third-trimester exposure does not usually increase the teratogenic risk and cognitive development, but it may increase the risk of poor obstetric outcome and fetal myelosuppression. During the first two weeks after fertilization of the embryo, radiation is lethal but not teratogenic. High doses of radiation during pregnancy induce anomalies, impaired growth and mental retardation, and there may be an increased risk of childhood leukaemia and other tumours in the offspring.
Similar articles
-
Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data.J Natl Cancer Inst Monogr. 2005;(34):21-5. doi: 10.1093/jncimonographs/lgi025. J Natl Cancer Inst Monogr. 2005. PMID: 15784816 Review.
-
Protection of the gametes embryo/fetus from prenatal radiation exposure.Health Phys. 2015 Feb;108(2):242-74. doi: 10.1097/HP.0000000000000235. Health Phys. 2015. PMID: 25551507 Review.
-
Is there evidence of a therapy-related increase in germ cell mutation among childhood cancer survivors?J Natl Cancer Inst. 1991 Nov 20;83(22):1643-50. doi: 10.1093/jnci/83.22.1643. J Natl Cancer Inst. 1991. PMID: 1749017
-
[Cancer and pregnancy: risks of exposure to cancer chemotherapy during pregnancy].J Gynecol Obstet Biol Reprod (Paris). 2004 Feb;33(1 Suppl):S29-32. doi: 10.1016/s0368-2315(04)96661-6. J Gynecol Obstet Biol Reprod (Paris). 2004. PMID: 14968015 Review. French.
-
Sensitivity of germ cells and embryos to ionizing radiation.J Biol Regul Homeost Agents. 2004 Apr-Jun;18(2):106-14. J Biol Regul Homeost Agents. 2004. PMID: 15471212 Review.
Cited by
-
Birth outcome in women with breast cancer, cutaneous malignant melanoma, or Hodgkin's disease: a review.Clin Epidemiol. 2010 Dec 23;3:7-19. doi: 10.2147/CLEP.S12190. Clin Epidemiol. 2010. PMID: 21326655 Free PMC article.
-
TRAIP is involved in chromosome alignment and SAC regulation in mouse oocyte meiosis.Sci Rep. 2016 Jul 11;6:29735. doi: 10.1038/srep29735. Sci Rep. 2016. PMID: 27405720 Free PMC article.
-
Fertility Preservation in Women With Malignancy: Future Endeavors.Clin Med Insights Reprod Health. 2019 Sep 12;13:1179558119872490. doi: 10.1177/1179558119872490. eCollection 2019. Clin Med Insights Reprod Health. 2019. PMID: 31548799 Free PMC article. Review.
-
Molecular Mechanism of Male Sterility Induced by 60Co γ-Rays on Plutella xylostella (Linnaeus).Molecules. 2023 Jul 28;28(15):5727. doi: 10.3390/molecules28155727. Molecules. 2023. PMID: 37570697 Free PMC article.
-
Practical consensus recommendations on fertility preservation in patients with breast cancer.South Asian J Cancer. 2018 Apr-Jun;7(2):110-114. doi: 10.4103/sajc.sajc_113_18. South Asian J Cancer. 2018. PMID: 29721475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
